Target Price | €17.82 |
Price | €9.72 |
Potential |
83.34%
register free of charge
|
Number of Estimates | 10 |
10 Analysts have issued a price target Evotec 2025 .
The average Evotec target price is €17.82.
This is
83.34%
register free of charge
€50.00
414.40%
register free of charge
€7.00
27.98%
register free of charge
|
|
A rating was issued by 11 analysts: 9 Analysts recommend Evotec to buy, 1 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Evotec stock has an average upside potential 2025 of
83.34%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million € | 781.43 | 875.43 |
3.99% | 12.03% | |
EBITDA Margin | -0.92% | 9.70% |
153.09% | 1,158.64% | |
Net Margin | -10.64% | -4.19% |
54.35% | 60.63% |
10 Analysts have issued a sales forecast Evotec 2024 . The average Evotec sales estimate is
This results in the following potential growth metrics:
5 Evotec Analysts have issued a net profit forecast 2024. The average Evotec net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share € | -0.47 | -0.21 |
52.53% | 55.32% | |
P/E | negative | |
EV/Sales | 2.10 |
5 Analysts have issued a Evotec forecast for earnings per share. The average Evotec <a href=/blog/eps>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Evotec stock is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.